SEPARATION AGREEMENT AND RELEASESeparation Agreement • May 25th, 2022 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Minnesota
This Separation Agreement (“Agreement”) and the Release, which is attached and incorporated by reference as Exhibit A (“Release”), are made by and between Harry Alcorn, Jr. Pharm.D. (“Executive”), and DiaMedica USA, Inc., its affiliates, related or predecessor corporations, parent, subsidiaries, successors and assigns (“Employer”).
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • May 25th, 2022 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Minnesota
NOW, THEREFORE, in consideration of the mutual covenants of the Parties set forth herein, the receipt and sufficiency of which are acknowledged by the Parties, the Parties hereto, intending to be legally bound, hereby agree as follows:
